Literature DB >> 10886192

Current status of antiangiogenic factors.

K L Talks1, A L Harris.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10886192     DOI： 10.1046/j.1365-2141.2000.01864.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis.

Authors:  Takashi Kojima; Jin-Hong Chang; Dimitri T Azar
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Koichi Uno; Carol Merges; Lei Zhang; D Scott McLeod; Gerard A Lutty
Journal:  Arch Ophthalmol       Date:  2008-05

3.  Clonality and altered behavior of endothelial cells from hemangiomas.

Authors:  E Boye; Y Yu; G Paranya; J B Mulliken; B R Olsen; J Bischoff
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 4.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis.

Authors:  Husni M Cangara; Tatsuro Ishida; Tetsuya Hara; Li Sun; Ryuji Toh; Yoshiyuki Rikitake; Ramendra K Kundu; Thomas Quertermous; Ken-ichi Hirata; Yoshitake Hayashi
Journal:  Microvasc Res       Date:  2010-02-11       Impact factor: 3.514

Review 6.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

7.  Selective inhibition of the human tie-1 promoter with triplex-forming oligonucleotides targeted to Ets binding sites.

Authors:  Peter W Hewett; Emma L Daft; Charles A Laughton; Shakil Ahmad; Asif Ahmed; J Clifford Murray
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

8.  Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus.

Authors:  Ewa Robak; Agnieszka Wierzbowska; Magdalena Chmiela; Liliana Kulczycka; Anna Sysa-Jedrejowska; Tadeusz Robak
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

9.  Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.

Authors:  E Van Valckenborgh; H De Raeve; L Devy; S Blacher; C Munaut; A Noël; E Van Marck; I Van Riet; B Van Camp; K Vanderkerken
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

10.  High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.

Authors:  Halina Urbańska-Ryś; Tadeusz Robak
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.